annual operating expenses:
$201.06M+$22.92M(+12.87%)Summary
- As of today (July 1, 2025), CNTA annual total operating expenses is $201.06 million, with the most recent change of +$22.92 million (+12.87%) on December 31, 2024.
- CNTA annual operating expenses is now -4.39% below its all-time high of $210.28 million, reached on December 31, 2022.
Performance
CNTA Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$45.78M-$28.80M(-38.62%)Summary
- As of today (July 1, 2025), CNTA quarterly total operating expenses is $45.78 million, with the most recent change of -$28.80 million (-38.62%) on March 31, 2025.
- Over the past year, CNTA quarterly operating expenses has increased by +$9.69 million (+26.84%).
- CNTA quarterly operating expenses is now -38.62% below its all-time high of $74.58 million, reached on December 31, 2024.
Performance
CNTA quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CNTA Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.9% | +26.8% |
| 3 y3 years | - | -10.7% |
| 5 y5 years | +3878.9% | +102.6% |
CNTA Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.4% | +12.9% | -38.6% | +26.8% |
| 5 y | 5-year | -4.4% | +1825.8% | -38.6% | +102.6% |
| alltime | all time | -4.4% | +3878.9% | -38.6% | +102.6% |
CNTA Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $45.78M(-38.6%) |
| Dec 2024 | $201.06M(+12.9%) | $74.58M(+60.7%) |
| Sep 2024 | - | $46.41M(+5.5%) |
| Jun 2024 | - | $43.98M(+21.9%) |
| Mar 2024 | - | $36.09M(-14.1%) |
| Dec 2023 | $178.14M(-15.3%) | $42.03M(+4.5%) |
| Sep 2023 | - | $40.21M(-14.5%) |
| Jun 2023 | - | $47.02M(-3.8%) |
| Mar 2023 | - | $48.88M(+17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $210.28M(+1914.2%) | $41.60M(-15.1%) |
| Sep 2022 | - | $49.03M(-28.3%) |
| Jun 2022 | - | $68.41M(+33.5%) |
| Mar 2022 | - | $51.24M(+33.7%) |
| Sep 2021 | - | $38.31M(+27.8%) |
| Jun 2021 | - | $29.98M(+7.5%) |
| Mar 2021 | - | $27.89M(+23.4%) |
| Dec 2020 | $10.44M(+106.6%) | - |
| Dec 2020 | - | $22.59M |
| Dec 2019 | $5.05M | - |
FAQ
- What is Centessa Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual operating expenses year-on-year change?
- What is Centessa Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly operating expenses year-on-year change?
What is Centessa Pharmaceuticals annual total operating expenses?
The current annual operating expenses of CNTA is $201.06M
What is the all time high annual operating expenses for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual total operating expenses is $210.28M
What is Centessa Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, CNTA annual total operating expenses has changed by +$22.92M (+12.87%)
What is Centessa Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of CNTA is $45.78M
What is the all time high quarterly operating expenses for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly total operating expenses is $74.58M
What is Centessa Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, CNTA quarterly total operating expenses has changed by +$9.69M (+26.84%)